首页> 外文期刊>DNA and Cell Biology >Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis
【24h】

Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis

机译:基于加权基因共存网络分析的早期生物标志物筛查前列腺癌

获取原文
获取原文并翻译 | 示例
           

摘要

Although the morbidity and mortality rates of prostate cancer (PCa) are considerably high, many PCas are characterized as indolent and slow growing, which do not require overtreatment. Overdiagnosis and overtreatment of early detected PCa are an emerging problem, owing to a lack of biomarkers that detect advanced disease at an earlier stage. In this study, RNA-Seq data of 57,045 genes for 495 PCa samples and 52 normal samples in the The Cancer Genome Atlas (TCGA) database were downloaded. Subsequently, we performed weighted gene coexpression network analysis to identify the Gleason score-related coexpression gene module, and further screened out oncogenes and tumor suppressors that were upregulated or downregulated in the early stage of PCa as well as those related to the clinical prognosis of PCa patients. Based on this study, some novel biomarkers were identified for the disease-free survival, which are helpful for fast diagnosis and prognosis.
机译:虽然前列腺癌(PCA)的发病率和死亡率相当高,但许多PCAS表征为惰性,缓慢生长,这不需要过度处理。 由于缺乏在早期阶段检测到晚期疾病的生物标志物,过度诊断和早期检测到的PCA的过度诊断是一种新兴问题。 在本研究中,下载了495个PCA样本的57,045个基因的RNA-SEQ数据和癌症基因组Atlas(TCGA)数据库中的52个正常样品。 随后,我们进行加权基因共存网络分析以鉴定Glason评分相关的共表达基因模块,并进一步筛选出在PCA早期上调或下调的癌肠和肿瘤抑制剂以及与PCA的临床预后相关的肿瘤抑制剂 耐心。 基于这项研究,鉴定了一些新的生物标志物用于无疾病存活率,这有助于快速诊断和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号